Pàgina inicial > Resultats de la cerca: Porta, Miquel,
  Consells de cerca
Cerca simple
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:

No s'ha trobat cap coincidència exacta per Porta, Miquel,, però canviant-lo per Porta Miquel ...
Dipòsit Digital de Documents de la UAB 30 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.02 segons. 
1.
4.1 MB Reticència vacunal en els professionals sanitaris de pediatria de Barcelona / Garcia Carrasco, Mireia ; Rius i Gibert, Maria Cristina, dir. ; Porta, Miquel, 1957-, dir.
Objectiu Conèixer la prevalença de reticència vacunal en el personal sanitari de pediatria dels centres d'atenció primària (CAP) de salut de Barcelona i identificar intervencions efectives per al seu abordatge entre el 2016 i el 2020. [...]
Objetivo Conocer la prevalencia de reticencia vacunal en el personal sanitario de pediatría de los centros de atención primaria (CAP) de salud de Barcelona e identificar intervenciones efectivas para su abordaje entre 2016 y 2020. [...]
Objective The objective was to known the vaccine hesitancy prevalence among paediatric healthcare workers of the primary health attention centres (CAP) in Barcelona city and to identify effective interventions to deal with it between 2016 and 2020. [...]
2023  
Registre complet - Creative Commons
2.
34 p, 1.9 MB Exposures to pesticides and risk of cancer : Evaluation of recent epidemiological evidence in humans and paths forward / Cavalier, Haleigh (Department of Population Health. New York University) ; Trasande, Leonardo (NYU School of Global Public Health) ; Porta, Miquel 1957- (Universitat Autònoma de Barcelona)
Knowledge of the role in cancer etiology of environmental exposures as pesticides is a prerequisite for primary prevention. We review 63 epidemiological studies on exposure to pesticides and cancer risk in humans published from 2017 to 2021, with emphasis on new findings, methodological approaches, and gaps in the existing literature. [...]
2023 - 10.1002/ijc.34300
International Journal of Cancer, Vol. 152 Núm. 5 (january 2023) , p. 879-912  
Registre complet - Creative Commons
3.
11.6 MB Eficacia de la radiofrecuencia monopolar capacitiva resistiva y de las técnicas de inducción miofascial en el síndrome de dolor pélvico crónico / Carralero Martínez, Andrea ; Muñoz Perez, Miguel Angel, dir. ; Ramírez García, Inés, dir. ; Porta Serra, Miquel, dir.
Antecedents La síndrome dolor pelvià crònic (SDPC) es defineix com a "dolor de causa no oncològica, intermitent o constant, en la part inferior de l'abdomen o de la pelvis, tant en homes com en dones, d'almenys 6 mesos de durada, i amb conseqüències negatives que poden ser de tipus cognitiu, conductual, sexual i emocional". [...]
Antecedentes El síndrome dolor pélvico crónico (SDPC) se define como "dolor de causa no oncológica, intermitente o constante, en la parte inferior del abdomen o de la pelvis, tanto en hombres como en mujeres, de al menos 6 meses de duración, y con consecuencias negativas que pueden ser de tipo cognitivo, conductual, sexual y emocional". [...]
Background Chronic pelvic pain syndrome (CPPS) is defined as "intermittent or constant non-cancer pain in the lower abdomen or pelvis, both in men and women, of at least 6 months duration, and with negative consequences that can be cognitive, behavioral, sexual and emotional. [...]
2022  
Registre complet - Creative Commons
4.
7.8 MB Caracterització, prevenció i control de la tuberculosi en poblacions vulnerables a Catalunya / Brugueras Torrella, Silvia ; Millet Vilanova, Joan Pau, dir. ; Rius i Gibert, Maria Cristina, dir. ; Porta Serra, Miquel, dir.
La tuberculosi (TB) és una malaltia infecciosa transmissible per via aèria, curable i prevenible que segueix sent un problema de salut pública mundial. Tant a Catalunya com a Barcelona, tot i que les incidències de TB es mantenen amb lleugera i insuficient tendència a la baixa, cada vegada augmenta més la complexitat dels casos. [...]
La tuberculosis (TB) es una enfermedad infecciosa transmisible por vía aérea, curable y prevenible que sigue siendo un problema de salud pública mundial. Tanto en Cataluña como en Barcelona, aunque las incidencias de TB se mantienen con ligera e insuficiente tendencia a la baja, cada vez aumenta más la complejidad de los casos. [...]
Tuberculosis (TB) is an airborne, curable, and preventable infectious disease that remains a global public health problem. Both in Catalonia and Barcelona, although the incidence of TB remains stable with a slight but insufficient downward trend, the complexity of the cases is increasing. [...]
2022  
Registre complet - Creative Commons
5.
11 p, 358.5 KB Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019 / Badia-Cebada, Laia (Universitat Autònoma de Barcelona. Facultat de Medicina) ; Peñafiel, Judit (Unit of Statistics. Hospital Universitari de Bellvitge. Institut d'Investigació Biomèdica de Bellvitge-IDIBELL) ; Saliba, Patrick (VINCat Programme. Infection Control Catalan Programme) ; Andrés, Marta (Infectious Diseases Unit, Department of Internal Medicine, Hospital Consorci de Terrassa, Spain) ; Càmara, Jordi (CIBER de Enfermedades Respiratorias (CIBERes). ISCIII) ; Domènech, Dolors (Hospital Universitari de Girona Doctor Josep Trueta) ; Jiménez-Martínez, Emili (Institut d'Investigació Biomèdica de Bellvitge) ; Marrón, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Moreno, Encarna (Infection Control Nurse, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain) ; Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ; Vaqué, Montserrat (Infection Control Nurse, Hospital de Barcelona, Barcelona) ; Limón, Enric (VINCat Programme. Infection Control Catalan Programme) ; Masats, Úrsula (Infection Control Nurse. Hospital Universitari Mútua Terrassa) ; Pujol, Miquel (Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat) ; Gasch Blasi, Oriol (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Jover, Alfredo (VINCat programme-Infection Control Catalan Programme) ; Castellana, Dolors (VINCat programme-Infection Control Catalan Programme) ; Olona, Montserrat (VINCat programme-Infection Control Catalan Programme) ; García Pino, Antonia (VINCat programme-Infection Control Catalan Programme) ; Rebull Fatsini, Josep (VINCat programme-Infection Control Catalan Programme) ; Domènech, Mª France (VINCat programme-Infection Control Catalan Programme) ; Pujol, Miquel (VINCat programme-Infection Control Catalan Programme) ; Hornero, Ana (VINCat programme-Infection Control Catalan Programme) ; Ardanuy Tisaire, Carmen (VINCat programme-Infection Control Catalan Programme) ; Berbel Palau, Dàmaris (VINCat programme-Infection Control Catalan Programme) ; López-Contreras, Joaquín (VINCat programme-Infection Control Catalan Programme) ; Fernández, Engracia (VINCat programme-Infection Control Catalan Programme) ; Salgado, Xavier (VINCat programme-Infection Control Catalan Programme) ; Lérida, Ana (VINCat programme-Infection Control Catalan Programme) ; Martin, Lydia (VINCat programme-Infection Control Catalan Programme) ; Sopena, Nieves (VINCat programme-Infection Control Catalan Programme) ; Casas García, Irma (VINCat programme-Infection Control Catalan Programme) ; Pérez, Rafael (VINCat programme-Infection Control Catalan Programme) ; Maraver, Encarna (VINCat programme-Infection Control Catalan Programme) ; Palau, Eva (VINCat programme-Infection Control Catalan Programme) ; Serrats, Pepi (VINCat programme-Infection Control Catalan Programme) ; Martínez, José Antonio (VINCat programme-Infection Control Catalan Programme) ; Santana, Gemina (VINCat programme-Infection Control Catalan Programme) ; Martínez, Ana (VINCat programme-Infection Control Catalan Programme) ; Ferrer, Lourdes (VINCat programme-Infection Control Catalan Programme) ; Moreno, Mª José (VINCat programme-Infection Control Catalan Programme) ; Calbo Sebastián, Esther (VINCat programme-Infection Control Catalan Programme) ; Porta, Carolina (VINCat programme-Infection Control Catalan Programme) ; Smithson, Alex (VINCat programme-Infection Control Catalan Programme) ; de la Roca Toda, Maria (VINCat programme-Infection Control Catalan Programme) ; Aliu, Teresa (VINCat programme-Infection Control Catalan Programme) ; Camps, Susana (VINCat programme-Infection Control Catalan Programme) ; Ortega, Montserrat (VINCat programme-Infection Control Catalan Programme) ; Diaz-Brito, Vicens (VINCat programme-Infection Control Catalan Programme) ; Moreno, Encarna (VINCat programme-Infection Control Catalan Programme) ; Agusti, Carme (VINCat programme-Infection Control Catalan Programme) ; Perea Garcia, Miquel (VINCat programme-Infection Control Catalan Programme) ; Andrés, Marta (VINCat programme-Infection Control Catalan Programme) ; Grau Palafox, Laura (VINCat programme-Infection Control Catalan Programme) ; Carrera, Raquel (VINCat programme-Infection Control Catalan Programme) ; Besolí, Anna (VINCat programme-Infection Control Catalan Programme) ; Horcajada, Juan Pablo (VINCat programme-Infection Control Catalan Programme) ; Gonzalez, Cristina (VINCat programme-Infection Control Catalan Programme) ; Cuquet, Jordi (VINCat programme-Infection Control Catalan Programme) ; Maldonado López, Demelsa Maria (VINCat programme-Infection Control Catalan Programme) ; Benítez, Rosa (VINCat programme-Infection Control Catalan Programme) ; Duch, Mireia (VINCat programme-Infection Control Catalan Programme) ; Blancas, David (VINCat programme-Infection Control Catalan Programme) ; Moreno, Esther (VINCat programme-Infection Control Catalan Programme) ; Villalba, Naiara (VINCat programme-Infection Control Catalan Programme) ; Martínez, Sara (VINCat programme-Infection Control Catalan Programme) ; García Flores, Àngels (VINCat programme-Infection Control Catalan Programme) ; Ferrer, Roser (VINCat programme-Infection Control Catalan Programme) ; Bisbe, Josep (VINCat programme-Infection Control Catalan Programme) ; Blascó, Montse (VINCat programme-Infection Control Catalan Programme) ; Castro Salom, Antoni (VINCat programme-Infection Control Catalan Programme) ; López, Ana Felisa (VINCat programme-Infection Control Catalan Programme) ; Espinach Alvarós, Joan (VINCat programme-Infection Control Catalan Programme) ; Perez, Àngels (VINCat programme-Infection Control Catalan Programme) ; Castander, David (VINCat programme-Infection Control Catalan Programme) ; Calaf, Elisabet (VINCat programme-Infection Control Catalan Programme) ; Clarós, Mercè (VINCat programme-Infection Control Catalan Programme) ; Bosch Ros, Núria (VINCat programme-Infection Control Catalan Programme) ; Montardit, Irene (VINCat programme-Infection Control Catalan Programme) ; Porta, Roser (VINCat programme-Infection Control Catalan Programme) ; De la Cruz Sol, Pilar (VINCat programme-Infection Control Catalan Programme) ; Coll Colell, Mª Rosa (VINCat programme-Infection Control Catalan Programme) ; García Penche Sanches, Rosa (VINCat programme-Infection Control Catalan Programme) ; Tricas, Josep Maria (VINCat programme-Infection Control Catalan Programme) ; Redon, Eva (VINCat programme-Infection Control Catalan Programme) ; Brugués, Montse (VINCat programme-Infection Control Catalan Programme) ; Linares, Laura (VINCat programme-Infection Control Catalan Programme) ; Cusco, Maria (VINCat programme-Infection Control Catalan Programme) ; Barrufet, Mª Pilar (VINCat programme-Infection Control Catalan Programme) ; Vidal, Elena (VINCat programme-Infection Control Catalan Programme) ; Barbadillo, Sandra (VINCat programme-Infection Control Catalan Programme) ; Marimón, Mariló (VINCat programme-Infection Control Catalan Programme) ; Meije, Yolanda (VINCat programme-Infection Control Catalan Programme) ; Vaqué, Montserrat (VINCat programme-Infection Control Catalan Programme) ; Laplace Enguinados, M.Rosa (VINCat programme-Infection Control Catalan Programme) ; Vila, Blanca (VINCat programme-Infection Control Catalan Programme) ; Coloma, Ana Guadalupe (VINCat programme-Infection Control Catalan Programme) ; López, Lucrecia (VINCat programme-Infection Control Catalan Programme) ; Campins Martí, Magda (VINCat programme-Infection Control Catalan Programme) ; Almirante Gragera, Benito (VINCat programme-Infection Control Catalan Programme) ; Ferrer, Carme (VINCat programme-Infection Control Catalan Programme) ; Juan Serra, Natalia (VINCat programme-Infection Control Catalan Programme) ; Farguell Carrera, Josep (VINCat programme-Infection Control Catalan Programme) ; Garcia Flores, Àngels (VINCat programme-Infection Control Catalan Programme) ; Ferrer, Roser (VINCat programme-Infection Control Catalan Programme) ; Milian Sanz, Marta (VINCat programme-Infection Control Catalan Programme) ; Moise, Alexandra (VINCat programme-Infection Control Catalan Programme) ; Jiménez Zarate, Ana Mª (VINCat programme-Infection Control Catalan Programme) ; Eito Navasal, M. Carmen (VINCat programme-Infection Control Catalan Programme) ; Garcia Ramirez, María Gracia (VINCat programme-Infection Control Catalan Programme) ; Armario Fernández, Mar (VINCat programme-Infection Control Catalan Programme) ; Universitat Autònoma de Barcelona
Background: Catheter-related bloodstream infections (CRBSI) are frequent healthcare-associated infections and an important cause of death. Aim: To analyse changes in CRBSI epidemiology observed by the Infection Control Catalan Programme (VINCat). [...]
2022 - 10.2807/1560-7917.ES.2022.27.19.2100610
Eurosurveillance, Vol. 27 Núm. 19 (december 2022) , p. 2100610  
Registre complet - Creative Commons
6.
2 p, 585.3 KB "Epidemiología cercana. La salud pública, la carne y el oxidado cuchillo del miedo" el nou llibre de Miquel Porta / Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Miquel Porta és un investigador i catedràtic de salut pública a l'Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) i la Facultat de Medicina de la Universitat Autònoma de Barcelona. També ha presidit les respectives associacions d'epidemiòlegs espanyols i europeus. [...]
Miquel Porta es un investigador y catedrático de salud pública en el Instituto Hospital del Mar de Investigaciones Médicas (IMIM) y la Facultad de Medicina de la Universitat Autònoma de Barcelona. [...]
2022
UAB divulga, Juny 2022
2 documents
Registre complet - Creative Commons
7.
20 p, 1.1 MB Trends in Citations to Books on Epidemiological and Statistical Methods in the Biomedical Literature / Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Vandenbroucke, Jan P. (Leiden University Medical Center, The Netherlands) ; Ioannidis, John P. A. (Stanford University School of of Humanities and Sciences, California, United States of America) ; Sanz, Sergio (Institut Hospital del Mar d'Investigacions Mèdiques) ; Fernandez, Esteve (Institut d'Investigació Biomèdica de Bellvitge) ; Bhopal, Raj (University of Edinburgh, Scotland, United Kingdom) ; Morabia, Alfredo (City University of New York, United States of America) ; Victora, Cesar (Universidade Federal de Pelotas, Brazil) ; Lopez, Tomàs (Institut Hospital del Mar d'Investigacions Mèdiques)
There are no analyses of citations to books on epidemiological and statistical methods in the biomedical literature. Such analyses may shed light on how concepts and methods changed while biomedical research evolved. [...]
2013 - 10.1371/journal.pone.0061837
PloS one, Vol. 8 (may 2013)  
Registre complet - Creative Commons
8.
16 p, 600.2 KB Number of Persistent Organic Pollutants Detected at High Concentrations in Blood Samples of the United States Population / Pumarega, José Antonio (Institut Hospital del Mar d'Investigacions Mèdiques) ; Gasull, Magda (Institut Hospital del Mar d'Investigacions Mèdiques) ; Lee, Duk-Hee (Kyungpook National University, Daegu, Korea) ; López, Tomàs (Institut Hospital del Mar d'Investigacions Mèdiques) ; Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Human exposure to environmental chemicals as persistent organic pollutants (POPs) is usually assessed considering each pollutant individually, with little attention to concentrations of mixtures in individuals or social groups. [...]
2016 - 10.1371/journal.pone.0160432
PloS one, Vol. 11 (august 2016)  
Registre complet - Creative Commons
9.
11 p, 1.8 MB Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer / Klein, Alison P. (Johns Hopkins School of Medicine, Baltimore, USA) ; Wolpin, Brian M. (Dana-Farber Cancer Institute, Boston, USA) ; Risch, Harvey A. (Yale School of Public Health, New Haven, USA) ; Stolzenberg-Solomon, Rachael Z. (National Institutes of Health, Bethesda, USA) ; Mocci, Evelina (Johns Hopkins School of Medicine, Baltimore, USA) ; Zhang, Mingfeng (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Canzian, Federico (Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Childs, Erica J. (Johns Hopkins School of Medicine, Baltimore, USA) ; Hoskins, Jason W. (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Jermusyk, Ashley (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Zhong, Jun (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Chen, Fei (Johns Hopkins School of Medicine, Baltimore, USA) ; Albanes, Demetrius (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Andreotti, Gabriella (National Institutes of Health, Bethesda, USA) ; Arslan, Alan A. (New York University School of Medicine, New York, USA) ; Babic, Ana (Dana-Farber Cancer Institute, Boston, USA) ; Bamlet, William R. (Mayo Clinic College of Medicine, Rochester, USA) ; Beane-Freeman, Laura (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; Berndt, Sonja (National Institutes of Health, Bethesda, USA) ; Blackford, Amanda (Johns Hopkins School of Medicine, Baltimore, USA) ; Borges, Michael (Johns Hopkins School of Medicine, Baltimore, USA) ; Borgida, Ayelet (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, M5G 1×5, Canada.) ; Bracci, Paige M. (University of California, San Francisco, USA) ; Brais, Lauren (Dana-Farber Cancer Institute, Boston, USA) ; Brennan, Paul (International Agency for Research on Cancer (IARC), Lyon, France) ; Brenner, Hermann (Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Bueno-de-Mesquita, Bas (National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands) ; Buring, Julie (Division of Preventive Medicine, Brigham and Women's Hospital, Boston) ; Campa, Daniele (University of Pisa) ; Capurso, Gabriele (University of Rome) ; Cavestro, Giulia Martina (Vita-Salute San Raffaele University, Milan) ; Chaffee, Kari G (Mayo Clinic College of Medicine, Rochester, USA) ; Chung, Charles C. (National Institutes of Health, Bethesda, USA) ; Cleary, Sean (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; Cotterchio, Michelle (University of Toronto.) ; Dijk, Frederike (University of Amsterdam. Department of Pathology, Academic Medical Center) ; Duell, Eric J. (Institut d'Investigació Biomèdica de Bellvitge) ; Foretova, Lenka (Masaryk Memorial Cancer Institute. Department of Cancer Epidemiology and Genetics, Brno, Czech Republic.) ; Fuchs, Charles (Yale Cancer Center, New Haven, USA) ; Funel, Niccola (University of Pisa.) ; Gallinger, Steven (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; M. Gaziano, J. Michael (Boston VA Healthcare System) ; Gazouli, Maria (National and Kapodistrian University of Athens) ; Giles, Graham G. (Monash University. Department of Epidemiology and Preventive Medicine, Melbourne, Australia) ; Giovannucci, Edward (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Goggins, Michael (Johns Hopkins School of Medicine. Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Baltimore) ; Goodman, Gary E. (Fred Hutchinson Cancer Research Center. Division of Public Health Sciences, Seattle, USA) ; Goodman, Phyllis J. (Fred Hutchinson Cancer Research Center. SWOG Statistical Center, Seattle, USA) ; Hackert, Thilo (University Hospital Heidelberg, Germany) ; Haiman, Christopher A (University of Southern California, USA) ; Hartge, Patricia (National Institutes of Health, Bethesda, USA) ; Hasan, Manal (University of Texas MD Anderson Cancer Center, USA) ; Hegyi, Peter (University of Szeged, Szeged, Hungary) ; Helzlsouer, Kathy J. (National Institutes of Health, Bethesda, USA) ; Herman, Joseph (Johns Hopkins School of Medicine. Baltimore, USA) ; Holcatova, Ivana (Charles University, Prague, Czech Republic) ; Holly, Elizabeth A. (University of California, San Francisco) ; Hoover, Robert (National Institutes of Health, Bethesda, USA) ; Hung, Rayjean J. (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada) ; Jacobs, Eric J. (American Cancer Society. Epidemiology Research Program, Atlanta) ; Jamroziak, Krzysztof (Institute of Hematology and Transfusion Medicine, Warsaw, Poland) ; Janout, Vladimir (Faculty of Medicine, University of Olomouc, Czech Republic) ; Kaaks, Rudolf (German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Khaw, Kay-Tee (University of Cambridge) ; Klein, Eric A. (Cleveland Clinic) ; Kogevinas, M (Hospital del Mar (Barcelona, Catalunya)) ; Kooperberg, Charles (Fred Hutchinson Cancer Research Center, Seattle) ; Kulke, Matthew H. (Dana-Farber Cancer Institute, Boston) ; Kupcinskas, Juozas (Lithuanian University of Health Sciences, Kaunas, Lithuania) ; Kurtz, Robert J. (Memorial Sloan Kettering Cancer Center, New York, USA) ; Laheru, Daniel (Johns Hopkins School of Medicine, Baltimore, USA) ; Landi, Stefano (University of Pisa) ; Lawlor, Rita T. (University and Hospital Trust of Verona) ; Lee, I.-Min (Harvard School of Public Health, Boston) ; LeMarchand, Loic (University of Hawaii Cancer Center, Honolulu, USA) ; Lu, Lingeng (Yale School of Public Health, New Haven, USA) ; Malats, Núria (Centro de Investigación Biomédica en Red de Cáncer, Madrid) ; Mambrini, Andrea (Oncology Department, ASL1 Massa Carrara, Italy) ; Mannisto, Satu (National Institute for Health and Welfare, Helsinki, Finland) ; Milne, Roger L. (The University of Melbourne, Australia) ; Mohelníková-Duchoňová, Beatrice (Palacky University Olomouc and University Hospital, Czech Republic) ; Neale, Rachel E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ; Neoptolemos, John P. (University of Heidelburg, Heidelberg, Germany) ; Oberg, Ann L. (Mayo Clinic College of Medicine, Rochester, USA) ; Olson, Sara H. (Memorial Sloan Kettering Cancer Center, New York, USA) ; Orlow, Irene (Memorial Sloan Kettering Cancer Center, New York, USA) ; Pasquali, Claudio (University of Padua, Italy) ; Patel, Alpa V. (American Cancer Society, Atlanta) ; Peters, Ulrike (Fred Hutchinson Cancer Research Center, Seattle) ; Pezzilli, Raffaele (Sant'Orsola-Malpighi Hospital, Bologna, Italy) ; Porta, Miquel 1957- (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Real, Francisco X. (Universitat Pompeu Fabra) ; Rothman, Nathaniel (National Institutes of Health, Bethesda, USA) ; Scelo, Ghislaine (International Agency for Research on Cancer (IARC), Lyon, France) ; Sesso, Howard D. (Harvard T.H. Chan School of Public Health. Department of Epidemiology) ; Severi, Gianluca (Université Paris-Saclay, France) ; Shu, Xiao-Ou (Vanderbilt University School of Medicine, Nashville, USA) ; Silverman, Debra (National Institutes of Health, Bethesda, USA) ; Smith, Jill P. (Georgetown University, Washington, USA) ; Soucek, Pavel (Charles University, Pilsen, Czech Republic.) ; Sund, Malin (Umeå University, Sweden) ; Talar-Wojnarowska, Renata (Medical University of Łodz, Poland) ; Tavano, Francesca (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Italy) ; Thornquist, Mark D. (Fred Hutchinson Cancer Research Center, Seattle) ; Tobias, Geoffrey S. (National Institutes of Health, Bethesda, USA) ; Van Den Eeden, Stephen K. (Kaiser Permanente Northern California, USA) ; Vashist, Yogesh (University Hamburg-Eppendorf, Germany) ; Visvanathan, Kala (Johns Hopkins Bloomberg School of Public Health, Baltimore, USA) ; Vodicka, Pavel (Academy of Sciences of the Czech Republic, Prague, Czech Republic) ; Wactawski-Wende, Jean (University at Buffalo, USA) ; Wang, Zhaoming (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Wentzensen, Nicolas (National Cancer Institute, National Institutes of Health, Bethesda, USA) ; White, Emily (University of Washington, USA) ; Yu, Herbert (University of Hawaii Cancer Center, USA) ; Yu, Kai (National Institutes of Health, Bethesda, USA) ; Zeleniuch-Jacquotte, Anne (New York University School of Medicine, USA) ; Zheng, Wei (Vanderbilt University School of Medicine, Nashville, USA) ; Kraft, Peter (Harvard School of Public Health, USA) ; Li, Donghui (University of Texas MD Anderson Cancer Center, USA) ; Chanock, Stephen (National Institutes of Health, Bethesda, USA) ; Obazee, Ofure (German Cancer Research Center (DKFZ), Heidelberg, Germany) ; Petersen, Gloria M. (Mayo Clinic College of Medicine, Rochester, USA) ; Amundadottir, Laufey T. (National Cancer Institute (Bethesda, Estats Units d'Amèrica))
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). [...]
2018 - 10.1038/s41467-018-02942-5
Nature communications, Vol. 9 (february 2018)  
Registre complet - Creative Commons
10.
122 p, 1.3 MB Anàlisi de la contaminació de la població general per compostos tòxics persistents i d'alguns dels seus efectes adversos per a la salut / Gasull, Magda ; Porta, Miquel, 1957-, dir. ; Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva
L'objectiu principal de la recerca realitzada és analitzar la contaminació de la població general per compostos tòxics persistents (CTPs) i estudiar la relació de les concentracions corporals d'aquests contaminants amb alguns dels seus possibles efectes adversos en la salut humana. [...]
The main aims of the research are to analyse the contamination of the general population by persistent toxic pollutants (PTS), as well as to study the relation between body concentrations of such compounds and some their possible adverse health effects. [...]
2019  
Registre complet - Creative Commons

Dipòsit Digital de Documents de la UAB : 30 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem